Encochleated miriplatin (Matinas BioPharma)

N/A

Report date: 2024/06/07 14:34:17

Base Information

Drug NameEncochleated miriplatin (Matinas BioPharma)
Drug Alias NameLNC-miriplatin (Matinas BioPharma)
ClassificationSmall molecules
Mechanisms of ActionDNA cross linking agentsDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMatinas Biopharma Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesMatinas Biopharma Holdings Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A